Hemab Therapeutics Holdings, Inc. Common Stock
Status: Publicly traded
Direct answer
Hemab Therapeutics Holdings, Inc. Common Stock is publicly traded on NASDAQ under the ticker COAG.
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for...
Can you invest in Hemab Therapeutics Holdings, Inc. Common Stock?
Yes. Hemab Therapeutics Holdings, Inc. Common Stock trades publicly on NASDAQ as COAG.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hemab Therapeutics Holdings, Inc. Common Stock
Detailed equity research is provided by MarketSnap.